These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 9352909
1. Characterization of DNA topoisomerase activity in two strains of Mycoplasma fermentans and in Mycoplasma pirum. Horowitz S, Maor R, Priel E. J Bacteriol; 1997 Nov; 179(21):6626-32. PubMed ID: 9352909 [Abstract] [Full Text] [Related]
2. Mycoplasma fermentans inhibits the activity of cellular DNA topoisomerase I by activation of PARP1 and alters the efficacy of its anti-cancer inhibitor. Afriat R, Horowitz S, Priel E. PLoS One; 2013 Nov; 8(8):e72377. PubMed ID: 24013388 [Abstract] [Full Text] [Related]
3. A human small cell lung carcinoma cell line, resistant to 4'-(9-acridinylamino)-methanesulfon-m-anisidide and cross-resistant to camptothecin with a high level of topoisomerase I. Prost S, Riou G. Biochem Pharmacol; 1994 Aug 30; 48(5):975-84. PubMed ID: 8093110 [Abstract] [Full Text] [Related]
4. Topoisomerase IV, not gyrase, decatenates products of site-specific recombination in Escherichia coli. Zechiedrich EL, Khodursky AB, Cozzarelli NR. Genes Dev; 1997 Oct 01; 11(19):2580-92. PubMed ID: 9334322 [Abstract] [Full Text] [Related]
5. Negative supercoiling of DNA by gyrase is inhibited in Salmonella enterica serovar Typhimurium during adaptation to acid stress. Colgan AM, Quinn HJ, Kary SC, Mitchenall LA, Maxwell A, Cameron ADS, Dorman CJ. Mol Microbiol; 2018 Mar 01; 107(6):734-746. PubMed ID: 29352745 [Abstract] [Full Text] [Related]
6. DNA topoisomerases I and II in human mature sperm cells: characterization and unique properties. Har-Vardi I, Mali R, Breietman M, Sonin Y, Albotiano S, Levitas E, Potashnik G, Priel E. Hum Reprod; 2007 Aug 01; 22(8):2183-9. PubMed ID: 17656417 [Abstract] [Full Text] [Related]
7. The function of DNA topoisomerases in UV-induced DNA excision repair: studies with specific inhibitors in permeabilized human fibroblasts. Popanda O, Thielmann HW. Carcinogenesis; 1992 Dec 01; 13(12):2321-8. PubMed ID: 1335377 [Abstract] [Full Text] [Related]
8. Escherichia coli DNA topoisomerase III: purification and characterization of a new type I enzyme. Srivenugopal KS, Lockshon D, Morris DR. Biochemistry; 1984 Apr 24; 23(9):1899-906. PubMed ID: 6326814 [Abstract] [Full Text] [Related]
9. Modulation of 4'-(9-acridinylamino)methanesulfon-m-anisidide-induced, topoisomerase II-mediated DNA cleavage by gossypol. Adlakha RC, Ashorn CL, Chan D, Zwelling LA. Cancer Res; 1989 Apr 15; 49(8):2052-8. PubMed ID: 2539251 [Abstract] [Full Text] [Related]
10. The interaction of Escherichia coli topoisomerase IV with DNA. Peng H, Marians KJ. J Biol Chem; 1995 Oct 20; 270(42):25286-90. PubMed ID: 7559669 [Abstract] [Full Text] [Related]
11. Studies on DNA polymerases and topoisomerases in archaebacteria. Forterre P, Elie C, Sioud M, Hamal A. Can J Microbiol; 1989 Jan 20; 35(1):228-33. PubMed ID: 2541877 [Abstract] [Full Text] [Related]
12. The influence of antibiotics and antitumor agents on the relaxation activity of Pisum sativum leaf chloroplast topoisomerase I. Zagariya AM, Sitailo LA. Arch Biochem Biophys; 1995 Jun 20; 320(1):177-81. PubMed ID: 7793978 [Abstract] [Full Text] [Related]
13. Preferential relaxation of positively supercoiled DNA by E. coli topoisomerase IV in single-molecule and ensemble measurements. Crisona NJ, Strick TR, Bensimon D, Croquette V, Cozzarelli NR. Genes Dev; 2000 Nov 15; 14(22):2881-92. PubMed ID: 11090135 [Abstract] [Full Text] [Related]
14. Bacterial topoisomerase I and topoisomerase III relax supercoiled DNA via distinct pathways. Terekhova K, Gunn KH, Marko JF, Mondragón A. Nucleic Acids Res; 2012 Nov 01; 40(20):10432-40. PubMed ID: 22923519 [Abstract] [Full Text] [Related]
15. Interaction of strong DNA-intercalating bioreductive compounds with topoisomerases I and II. Rosenzweig HS, Papadopoulou MV, Bloomer WD. Oncol Res; 2005 Nov 01; 15(4):219-31. PubMed ID: 17822282 [Abstract] [Full Text] [Related]
16. Mutations reducing replication from R-loops suppress the defects of growth, chromosome segregation and DNA supercoiling in cells lacking topoisomerase I and RNase HI activity. Usongo V, Martel M, Balleydier A, Drolet M. DNA Repair (Amst); 2016 Apr 01; 40():1-17. PubMed ID: 26947024 [Abstract] [Full Text] [Related]
17. [DNA supercoiling and topoisomerases in Escherichia coli]. Gómez-Eichelmann MC, Camacho-Carranza R. Rev Latinoam Microbiol; 1995 Apr 01; 37(3):291-304. PubMed ID: 8850348 [Abstract] [Full Text] [Related]
18. Inhibitory properties of antitumor prostaglandins against topoisomerases. Suzuki K, Uyeda M. Biosci Biotechnol Biochem; 2002 Aug 01; 66(8):1706-12. PubMed ID: 12353631 [Abstract] [Full Text] [Related]
19. Response of purified mitochondrial DNA topoisomerase I from bovine liver to camptothecin and m-AMSA. Lin JH, Castora FJ. Arch Biochem Biophys; 1995 Dec 20; 324(2):293-9. PubMed ID: 8554321 [Abstract] [Full Text] [Related]
20. CK2-mediated hyperphosphorylation of topoisomerase I targets serine 506, enhances topoisomerase I-DNA binding, and increases cellular camptothecin sensitivity. Bandyopadhyay K, Li P, Gjerset RA. PLoS One; 2012 Dec 20; 7(11):e50427. PubMed ID: 23185622 [Abstract] [Full Text] [Related] Page: [Next] [New Search]